Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:17 pm Sale | 2023-12-31 | 13G | MADISON SQUARE GARDEN ENTMT CO MSGE | Point72 Asset Management, L.P. | 2,299,168 5.600% | -4,445 (-0.19%) | Filing History |
| 2024-02-14 4:16 pm Purchase | 2023-12-31 | 13G | TPI COMPOSITES INC TPICQ | Point72 Asset Management, L.P. | 3,286,322 7.100% | 1,154,151 (+54.13%) | Filing History |
| 2024-02-14 4:15 pm Purchase | 2023-12-31 | 13G | MORPHIC HLDG INC MORF | Point72 Asset Management, L.P. | 4,591,000 9.200% | 2,086,617 (+83.32%) | Filing History |
| 2024-02-14 4:14 pm Sale | 2023-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Point72 Asset Management, L.P. | 3,416,900 5.100% | -311,052 (-8.34%) | Filing History |
| 2024-02-14 4:14 pm Purchase | 2023-12-31 | 13G | CYBIN INC HELP | Point72 Asset Management, L.P. | 30,061,112 7.400% | 11,111,112 (+58.63%) | Filing History |
| 2024-02-14 4:13 pm Purchase | 2023-12-31 | 13G | HEALTH CATALYST INC HCAT | Point72 Asset Management, L.P. | 4,159,454 7.200% | 1,334,524 (+47.24%) | Filing History |
| 2024-02-14 4:12 pm Sale | 2023-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management, L.P. | 758,185 8.600% | -3,649 (-0.48%) | Filing History |
| 2024-02-14 4:11 pm Purchase | 2023-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management, L.P. | 5,243,623 6.100% | 1,680,721 (+47.17%) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | Point72 Asset Management, L.P. | 4,040,000 9.400% | 1,918,830 (+90.46%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Point72 Asset Management, L.P. | 493,400 0.900% | -3,021,956 (-85.96%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 3,974,873 4.200% | -3,727,958 (-48.40%) | Filing History |
| 2024-02-14 10:04 am Sale | 2023-12-31 | 13G | FIBROGEN INC FGEN | Point72 Asset Management, L.P. | 65,754 1.700% | -185,512 (-73.83%) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | EOS ENERGY ENTERPRISES INC EOSE | Point72 Asset Management, L.P. | 3,840,704 2.000% | -1,694,326 (-30.61%) | Filing History |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 62,511 1.400% | -130,889 (-67.68%) | Filing History |
| 2024-02-14 10:02 am Purchase | 2023-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Point72 Asset Management, L.P. | 2,500 0.300% | 414 (+19.85%) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management, L.P. | 788,545 3.000% | -1,335,655 (-62.88%) | Filing History |
| 2024-02-14 08:56 am Sale | 2023-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Point72 Asset Management, L.P. | 822,334 3.000% | -743,495 (-47.48%) | Filing History |
| 2024-02-14 07:16 am Purchase | 2023-12-31 | 13G | FARFETCH LTD FTCHQ | Point72 Asset Management, L.P. | 20,383,303 5.800% | 1,617,894 (+8.62%) | Filing History |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management, L.P. | 2,613,453 4.500% | -572,624 (-17.97%) | Filing History |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Point72 Asset Management, L.P. | 3,202,381 4.700% | -268,310 (-7.73%) | Filing History |